Considerations in the formulary selection of hydroxymethylglutaryl-coenzyme A reductase inhibitors.
McMillan
K
K
Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee, Memphis 38163, USA. kmcmillan@utmem1.utmem.edu
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005572:Formularies, Hospital as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors